Advertisement
Advertisement

PFE

PFE logo

Pfizer Inc.

27.23
USD
Sponsored
+0.74
+2.79%
Feb 06, 16:00 UTC -5
Closed
exchange

After-Market

27.16

-0.07
-0.27%

PFE Earnings Reports

Positive Surprise Ratio

PFE beat 35 of 40 last estimates.

88%

Next Report

Date of Next Report
Apr 27, 2026
Estimate for Q1 26 (Revenue/ EPS)
$14.19B
/
$0.75
Implied change from Q4 25 (Revenue/ EPS)
-19.20%
/
+13.64%
Implied change from Q1 25 (Revenue/ EPS)
+3.44%
/
-18.48%

Pfizer Inc. earnings per share and revenue

On Feb 03, 2026, PFE reported earnings of 0.66 USD per share (EPS) for Q4 25, beating the estimate of 0.57 USD, resulting in a 14.29% surprise. Revenue reached 17.56 billion, compared to an expected 17.12 billion, with a 2.56% difference. The market reacted with a -3.34% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 14 analysts forecast an EPS of 0.75 USD, with revenue projected to reach 14.19 billion USD, implying an increase of 13.64% EPS, and decrease of -19.20% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Sanofi - ADR
Report Date
Jan 29, 2026 For Q4 25
Estimate
$1.46
Actual
$1.53
Surprise
+4.22%
logo
Eli Lilly & Co.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$6.73
Actual
$7.54
Surprise
+11.92%
logo
ABBVIE INC.
Report Date
Feb 04, 2026 For Q4 25
Estimate
$2.70
Actual
$2.71
Surprise
+0.17%
logo
Novartis AG
Report Date
Feb 04, 2026 For Q4 25
Estimate
$2.02
Actual
$2.02
Surprise
+0.27%
logo
Merck & Co., Inc.
Report Date
Feb 03, 2026 For Q4 25
Estimate
$2.02
Actual
$2.04
Surprise
+0.52%
logo
Novo-Nordisk A/S
Report Date
Feb 04, 2026 For Q4 25
Estimate
$5.97
Actual
$6.32
Surprise
+5.77%
FAQ
For Q4 2025, Pfizer Inc. reported EPS of $0.66, beating estimates by 14.29%, and revenue of $17.56B, 2.56% above expectations.
The stock price moved down -3.34%, changed from $26.66 before the earnings release to $25.77 the day after.
The next earning report is scheduled for Apr 27, 2026.
Based on 14 analysts, Pfizer Inc. is expected to report EPS of $0.75 and revenue of $14.19B for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement